Drug Shortage Report for BUTRANS 10
Report ID | 160478 |
Drug Identification Number | 02341212 |
Brand name | BUTRANS 10 |
Common or Proper name | Buprenorphine Transdermal System |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | BUPRENORPHINE |
Strength(s) | 10MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 4 |
ATC code | N02AE |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-05-12 |
Actual start date | 2022-05-12 |
Estimated end date | 2022-06-10 |
Actual end date | 2022-05-30 |
Shortage status | Resolved |
Updated date | 2022-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-05-12 | English | Compare |
v2 | 2022-05-12 | French | Compare |
v3 | 2022-05-13 | English | Compare |
v4 | 2022-05-30 | English | Compare |
v5 | 2022-05-30 | French | Compare |
v6 | 2022-05-31 | English | Compare |
Showing 1 to 6 of 6